Position in NVO
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$3,051,381
+$692,031 QoQ
Shares Held
63,650
-0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#293
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EagleClaw Capital Managment, LLC holds $45,392,435 across 12 Drug Manufacturers - General names. NVO ranks #6 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
71,774 | $18,061,209 | |
| 2 | JNJ |
Johnson & Johnson
|
22,283 | $5,659,213 | |
| 3 | MRK |
Merck & Co., Inc.
|
30,088 | $3,866,308 | |
| 4 | NVS |
Novartis AG
|
23,712 | $3,716,144 | |
| 5 | PFE |
Pfizer Inc
|
153,401 | $3,693,896 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
63,650 | $3,051,381 | |
| 7 | LLY |
ELI LILLY & Co
|
1,772 | $2,125,390 | |
| 8 | SNY |
Sanofi
|
45,410 | $1,937,190 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,051,381 | 63,650 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,359,350 | 64,200 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $3,289,392 | 64,650 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,559,683 | 64,150 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,496,653 | 65,150 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $4,524,016 | 65,150 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $5,664,417 | 65,850 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $7,840,759 | 65,850 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $9,031,873 | 63,275 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $8,188,710 | 63,775 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $6,724,250 | 65,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,865,630 | 64,500 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $5,194,743 | 32,100 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $5,148,179 | 32,350 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $4,632,011 | 34,225 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,424,781 | 34,375 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $3,830,406 | 34,375 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $3,817,343 | 34,375 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,956,400 | 35,325 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,403,554 | 35,450 | Shares | Sole | 2021-12-02 | |
| 2021-06-30 | $3,162,317 | 37,750 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,479,370 | 36,775 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,476,182 | 35,450 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,718,184 | 39,150 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,511,158 | 38,350 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,483,250 | 41,250 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||